Petros Grivas, MD, PhD, Clinical Director of the Genitourinary Cancer Program and a Professor in the Division of Medical Oncology at Fred Hutch Cancer Center, highlights the practice-changing and informing studies that have come out of the ASCO GU 2023 Symposium – including TALAPRO-2, TRITON3, CheckMate 274, and COSMIC-313, among others.